VeriSign Other Income (Expense) decreased by 102.0% to -$400.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 63.6%, from -$1.10M to -$400.00K. Over 3 years (FY 2022 to FY 2025), Other Income (Expense) shows an upward trend with a 25.5% CAGR.
An increase suggests higher non-operating gains or lower non-operating costs, while a decrease indicates higher non-operating expenses or lower non-operating income.
Represents the net total of non-operating financial activities, including interest income, interest expense, foreign cur...
Standard across all public companies; peers in the medical device sector often show similar volatility due to currency fluctuations.
other_income_expense_net| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$2.04M | $164.00K | -$600.00K | -$900.00K | $4.90M | $9.00M | $2.90M | $4.40M | $13.10M | $30.80M | -$1.00M | -$600.00K | $10.50M | $30.10M | -$1.10M | -$300.00K | $6.30M | $19.60M | -$400.00K |
| QoQ Change | — | +108.0% | -465.9% | -50.0% | +644.4% | +83.7% | -67.8% | +51.7% | +197.7% | +135.1% | -103.2% | +40.0% | >999% | +186.7% | -103.7% | +72.7% | >999% | +211.1% | -102.0% |
| YoY Change | — | — | — | +55.9% | >999% | — | +583.3% | +588.9% | +167.3% | +242.2% | -134.5% | -113.6% | -19.8% | -2.3% | -10.0% | +50.0% | -40.0% | -34.9% | +63.6% |